Newsroom

News and announcements for Sutter Health Sacramento Sierra Region

Clinical Trial Begins on Vaccine Made from Patient’s Own Tumor

Posted by on Feb 8, 2012 in Cancer, Neurosciences, Sutter Health Sacramento Sierra Region, Sutter Medical Center, Sacramento | 0 comments

Newly-diagnosed brain cancer patients are being sought by Sutter Medical Center, Sacramento for a clinical trial of a vaccine that is made from a patient’s own tumor.

Dr. Nora Wu, along with a team of surgeons and physicians, has begun the DCVax®-L Phase II Clinical Trial at Sutter Medical Center in collaboration with the Sutter Institute for Medical Research. The study looks at the response of patients with Glioblastoma Multiforme (GBM) to a vaccine made from their own tumor in addition to standard radiation and chemotherapy.

In prior trials of DCVax®-L immune therapy for GBM brain cancer, the results were striking. The patients who received DCVax®-L showed a median survival of three years, compared with median survival of only 14.6 months with standard of care treatment (surgery, radiation and chemotherapy).

To be potentially eligible for the study, patients must: • Be between the ages of 18 and 70; • Have an MRI that is consistent with a malignant high-grade glioblastoma; • Be identified as candidates for the trial before surgical removal of the tumor.

To learn more about this trial, contact the Sutter Institute for Medical Research at (916) 733-8930. Additional information may be found at http://clinicaltrials.gov as well as the Northwest Biotherapeutics website, http://nwbio.com

Posted by on Feb 8, 2012 in Cancer, Neurosciences, Sutter Health Sacramento Sierra Region, Sutter Medical Center, Sacramento | 0 comments